The Mechanism of Action and Clinical Efficacy of Low-Dose Long-Term Macrolide Therapy in Chronic Rhinosinusitis
Various chronic inflammatory airway diseases can be treated with low-dose, long-term (LDLT) macrolide therapy. LDLT macrolides can be one of the therapeutic options for chronic rhinosinusitis (CRS) due to their immunomodulatory and anti-inflammatory actions. Currently, various immunomodulatory mecha...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/11/9489 |
_version_ | 1797597427399655424 |
---|---|
author | Gwanghui Ryu Eunkyu Lee Song I Park Minhae Park Sang Duk Hong Yong Gi Jung Hyo Yeol Kim |
author_facet | Gwanghui Ryu Eunkyu Lee Song I Park Minhae Park Sang Duk Hong Yong Gi Jung Hyo Yeol Kim |
author_sort | Gwanghui Ryu |
collection | DOAJ |
description | Various chronic inflammatory airway diseases can be treated with low-dose, long-term (LDLT) macrolide therapy. LDLT macrolides can be one of the therapeutic options for chronic rhinosinusitis (CRS) due to their immunomodulatory and anti-inflammatory actions. Currently, various immunomodulatory mechanisms of the LDLT macrolide treatment have been reported, as well as their antimicrobial properties. Several mechanisms have already been identified in CRS, including reduced cytokines such as interleukin (IL)-8, IL-6, IL-1β, tumor necrosis factor-α, transforming growth factor-β, inhibition of neutrophil recruitment, decreased mucus secretion, and increased mucociliary transport. Although some evidence of effectiveness for CRS has been published, the efficacy of this therapy has been inconsistent across clinical studies. LDLT macrolides are generally believed to act on the non-type 2 inflammatory endotype of CRS. However, the effectiveness of LDLT macrolide treatment in CRS is still controversial. Here, we reviewed the immunological mechanisms related to CRS in LDLT macrolide therapy and the treatment effects according to the clinical situation of CRS. |
first_indexed | 2024-03-11T03:05:55Z |
format | Article |
id | doaj.art-afa26d46d7084cd7a40ddac9933fd51d |
institution | Directory Open Access Journal |
issn | 1661-6596 1422-0067 |
language | English |
last_indexed | 2024-03-11T03:05:55Z |
publishDate | 2023-05-01 |
publisher | MDPI AG |
record_format | Article |
series | International Journal of Molecular Sciences |
spelling | doaj.art-afa26d46d7084cd7a40ddac9933fd51d2023-11-18T07:59:43ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-05-012411948910.3390/ijms24119489The Mechanism of Action and Clinical Efficacy of Low-Dose Long-Term Macrolide Therapy in Chronic RhinosinusitisGwanghui Ryu0Eunkyu Lee1Song I Park2Minhae Park3Sang Duk Hong4Yong Gi Jung5Hyo Yeol Kim6Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of KoreaDepartment of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of KoreaDepartment of Otorhinolaryngology-Head and Neck Surgery, Ilsan Paik Hospital, Inje University College of Medicine, Goyang 10380, Republic of KoreaDepartment of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of KoreaDepartment of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of KoreaDepartment of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of KoreaDepartment of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of KoreaVarious chronic inflammatory airway diseases can be treated with low-dose, long-term (LDLT) macrolide therapy. LDLT macrolides can be one of the therapeutic options for chronic rhinosinusitis (CRS) due to their immunomodulatory and anti-inflammatory actions. Currently, various immunomodulatory mechanisms of the LDLT macrolide treatment have been reported, as well as their antimicrobial properties. Several mechanisms have already been identified in CRS, including reduced cytokines such as interleukin (IL)-8, IL-6, IL-1β, tumor necrosis factor-α, transforming growth factor-β, inhibition of neutrophil recruitment, decreased mucus secretion, and increased mucociliary transport. Although some evidence of effectiveness for CRS has been published, the efficacy of this therapy has been inconsistent across clinical studies. LDLT macrolides are generally believed to act on the non-type 2 inflammatory endotype of CRS. However, the effectiveness of LDLT macrolide treatment in CRS is still controversial. Here, we reviewed the immunological mechanisms related to CRS in LDLT macrolide therapy and the treatment effects according to the clinical situation of CRS.https://www.mdpi.com/1422-0067/24/11/9489chronic rhinosinusitismacrolidecytokinesneutrophilsnasal polyps |
spellingShingle | Gwanghui Ryu Eunkyu Lee Song I Park Minhae Park Sang Duk Hong Yong Gi Jung Hyo Yeol Kim The Mechanism of Action and Clinical Efficacy of Low-Dose Long-Term Macrolide Therapy in Chronic Rhinosinusitis International Journal of Molecular Sciences chronic rhinosinusitis macrolide cytokines neutrophils nasal polyps |
title | The Mechanism of Action and Clinical Efficacy of Low-Dose Long-Term Macrolide Therapy in Chronic Rhinosinusitis |
title_full | The Mechanism of Action and Clinical Efficacy of Low-Dose Long-Term Macrolide Therapy in Chronic Rhinosinusitis |
title_fullStr | The Mechanism of Action and Clinical Efficacy of Low-Dose Long-Term Macrolide Therapy in Chronic Rhinosinusitis |
title_full_unstemmed | The Mechanism of Action and Clinical Efficacy of Low-Dose Long-Term Macrolide Therapy in Chronic Rhinosinusitis |
title_short | The Mechanism of Action and Clinical Efficacy of Low-Dose Long-Term Macrolide Therapy in Chronic Rhinosinusitis |
title_sort | mechanism of action and clinical efficacy of low dose long term macrolide therapy in chronic rhinosinusitis |
topic | chronic rhinosinusitis macrolide cytokines neutrophils nasal polyps |
url | https://www.mdpi.com/1422-0067/24/11/9489 |
work_keys_str_mv | AT gwanghuiryu themechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis AT eunkyulee themechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis AT songipark themechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis AT minhaepark themechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis AT sangdukhong themechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis AT yonggijung themechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis AT hyoyeolkim themechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis AT gwanghuiryu mechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis AT eunkyulee mechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis AT songipark mechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis AT minhaepark mechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis AT sangdukhong mechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis AT yonggijung mechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis AT hyoyeolkim mechanismofactionandclinicalefficacyoflowdoselongtermmacrolidetherapyinchronicrhinosinusitis |